PDE5A and Alzheimer disease: Combining HDAC (Histone Deacetylase) inhibitor with the inhibition of phosphodiesterase-5 (PDE5), an enzyme that targets another intracellular pathway has been proposed to be implicated in memory formation and other AD-related symptoms (Cuadrado-Tejedor et al., 2015).